KALYDECO: Vertex presents realworld data highlighting benefit of CF drug Kalydeco
Vertex has presented longterm observational data highlighting the benefit of Kalydeco in patients with cystic fibrosis.
Read full article »
CEO
Kalydeco is a Private company. Kalydeco generates $1M in revenue per employee Kalydeco has 3 followers on Owler.